Professor, Medicine - Blood and Marrow Transplantation, Stanford University Medical Center
Oncology
Dr. Ginna G. Laport, MD
|
|
Give Review
Dr. Ginna G. Laport is an expert in the field of Oncology. She went to medical school at University of Texas Medical School. She over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Ginna G. Laport, MD is a published doctor. She has 36 papers published. The most current publication "Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era." Ginna G. Laport, MD is registered with Medicare and accepts Medicare payments.
Publications
- Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem Cell transplantation: consensus opinion of the Blood and Marrow Transplan...
- Significant improvement in survival after unrelated donor hematopoietic Cell transplantation in the recent era.
- Alternative donors extend transplantation for patients with Lymphoma who lack an HLA matched donor.
- Allogeneic hematopoietic Cell transplantation for mycosis fungoides and Sezary syndrome.
- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014.
- Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with Myelodysplastic syndromes and myeloproliferative neopla...
- Selected Reviews from the 2014 BMT Tandem Meetings.
- Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin Lymphoma.
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- Autologous haematopoietic Cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma.
- Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic Cell transplantation.
- Anatomy of a Successful Practice-Changing Study: A Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group Collaboration.
- Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
- Tandem Transplantation for Follicular Lymphoma: The Best of Both Worlds?
- Follicular lymphoma: prognostic factors, conventional therapies, and hematopoietic Cell transplantation.
- Alternate donor hematopoietic Cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR.
- Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic Cell transplantation for advanced hematologic malignancies.
- Adoptive immunotherapy with cytokine-induced killer Cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic Cell transplantation.
- Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complet...
- Peripheral T-Cell lymphoma: autologous hematopoietic Cell transplantation as first-line therapy.
- Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic Cell transplantation in recurrent and refractory...
- TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic Cell transplantation from related and un...
- Long-term remission of Philadelphia chromosome-positive Acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a...
- Long-term results of autologous hematopoietic Cell transplantation for peripheral T Cell lymphoma: the Stanford experience.
- Reduced-intensity conditioning followed by allogeneic hematopoietic Cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disord...
- Controversies in lymphoma: the role of hematopoietic Cell transplantation for mantle Cell lymphoma and peripheral T Cell lymphoma.
- Mantle Cell lymphoma in first complete remission.
- High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic Cell transplantation for non-Hodgkin lymphoma.
- The role of hematopoietic Cell transplantation for follicular non-Hodgkin's lymphoma.
- Protective conditioning for Acute graft-versus-host disease.
- Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic Cell transplantation is affected by CD8+ T-Cell dose.
- Adoptive transfer of costimulated T Cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic Cell t...
- Nonmyeloablative allogeneic stem cell transplantation for Acute leukemia.
- European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with Acute myeloid leukemia undergoing allogeneic hematopoiet...
Schools
University of Texas At Houston Medical School At Houston
University Chicago Hospital
Stanford University Med Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
University of Texas Medical School
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1144370743 | |
| NPPES Provider LastName | LAPORT | |
| NPPES Provider FirstName | GINNA | |
| NPPES Provider ZIPCode | 943055623 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 634.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 4.1 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144370743 |
| Last Name Of The Provider | LAPORT |
| First Name Of The Provider | GINNA |
| View All |
Similar Doctors
|
|
Dr. Joseph A. Mollick, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Ford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kavitha J. Ramchandran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajat Rohatgi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Rogoway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren S. Maeda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dean Felsher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Y. Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold N. Keer, MD
This Doctor is OpenDoctor Recommended.
|